Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04165694 · ClinicalTrials.gov registry record · NA

Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision

A NA study of Bariatric Surgery Candidate and Severe Obesity, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
54
Enrollment target
1
Study location

NCT04165694: Active NA study of Bariatric Surgery Candidate and Severe Obesity, sponsored by Kaiser Permanente.

NCT04165694 is a NA study of Bariatric Surgery Candidate and Severe Obesity that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 54 participants, below the 111-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04165694, a NA study of Bariatric Surgery Candidate and Severe Obesity, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
54 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is two part: 1) to add to the literature which is still somewhat sparse with numbers of patients undergoing the Single Anastomosis Duodenal Ileal Bypass (SADI) as a revision for laparoscopic sleeve gastrectomy (LSG) and 2) to have a treatment option for our Kaiser Permanente patients who seek additional assistance after a LSG with persistent morbid obesity and the comorbidities that come with it.

Primary Outcome

This is weight loss relative to the initial body weight at the time of surgery calculated as (weight at surgery - weight at follow-up)/weight at surgery. This is already a change score.

Interventions

  • PROCEDURE Single Anastomosis Duodenal Ileal Bypass (SADI)

Study Locations (1)

California

  • Kaiser Permanente Southern California West Los Angeles Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2019-10-15
Est. Completion 2030-12-31
Phase NA
Kaiser Permanente

294 total trials

What the registry record for NCT04165694 still lists

NCT04165694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 111-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (51% lower).

The record links to 2 conditions, with Bariatric Surgery Candidate appearing as the primary indexed condition, and to 1 intervention - of which Single Anastomosis Duodenal Ileal Bypass (SADI) is the first listed.

NCT04165694 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04165694 about?

NCT04165694 is a clinical study titled "Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision". The goal of this study is two part: 1) to add to the literature which is still somewhat sparse with numbers of patients undergoing the Single Anastomosis Duodenal Ileal Bypass (SADI) as a revision for laparoscopic sleeve gastrectomy (LSG) and 2) to have a treatment option for our Kaiser Permanente p...

What is the current status of trial NCT04165694?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2019-10-15. Estimated completion is 2030-12-31.

What conditions does trial NCT04165694 study?

This clinical trial studies the following conditions: Bariatric Surgery Candidate, Severe Obesity.

What interventions are being tested in trial NCT04165694?

The interventions under investigation include: Single Anastomosis Duodenal Ileal Bypass (SADI) (PROCEDURE).

Who is sponsoring clinical trial NCT04165694?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04165694 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bariatric Surgery Candidate

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04165694's enrollment target sits among peer trials

54 17th of 28 higher than 12 of 28 other Bariatric Surgery Candidate trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bariatric Surgery Candidate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269853 · 54 participants · Phase 1

    Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

  • NCT02390752 · 54 participants · Phase 1

    Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

  • NCT02991248 · 54 participants · NA

    Improve Dynamic Lateral Balance of Humans With SCI

  • NCT02993900 · 54 participants · NA

    Image-Guided Gynecologic Brachytherapy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04165694, the US trial registry maintained by the National Library of Medicine. NCT04165694 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.